BioCrea GmbH (BioCrea) is a healthcare company that offers drug discovery services. The company discovers and develops drugs to treat debilitating central nervous system diseases. It provides pipeline product PDE10, an inhibitor to treat Schizophrenia and Huntington’s disease. BioCrea offers discovery platforms such as NMDA-receptor negative allosteric modulators for treatment resistant depression and major depressive disorder, GABA positive allosteric modulators for treatment of refractory epilepsy and autism spectrum disorders. The company provides novel ALS treatments from a patient-to-screen phenotypic discovery platform that integrates patient derived induced pluripotent stem cells into the screening and profiling process. It operates through pharmaceutical companies located in Germany. BioCrea is headquartered in Radebeul, Germany.
BioCrea GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. - Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. - Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. - Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. - Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector. - Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios. - Business Description - A brief description of the company's operations. - Key Employees - A list of the key executives of the company. - Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company. - Key Competitors - A list of the key competitors of the company. - Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements - The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy - The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company - Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers. - The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company - Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research - Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Our reports have been used by over 10K customers, including:
494 pages •
By Global Industry Analysts
• Jul 2022
Abstract: What`s New for 2022? - Global competitiveness and key competitor percentage market shares - Market presence across multiple geographies - Strong/Active/Niche/Trivial - Online interactive peer-to-peer collaborative bespoke updates - Access to our digital archives and MarketGlass...
The report considers the present scenario of the global mental wellness market and its market dynamics for 2022?2027. It covers a detailed overview of several market growth enablers, restraints, and trends. The study covers both the demand and supply sides of the market. It also profiles and analyses leading companies and several other prominent...
Dyskinesia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary This latest Pharmaceutical and Healthcare disease pipeline guide Dyskinesia - Drugs In Development, 2022, provides an overview of the Dyskinesia (Central Nervous System) pipeline landscape. Dyskinesia...
175 pages •
By The Business Research Company
• Jun 2022
Major players in the narcotics scanner market are Astrophysics Inc, Bruker Corporation, Thermo Fisher Scientific Inc, KLIPPER Enterprises, NUCTECH Company Ltd, OSI Systems Inc, Smiths Group Plc, Leidos, Viken Detection, Autoclear, Kapri Corp, CDex Inc, TactiScan, DetectaChem, and Rapiscan Systems. The global narcotics scanner market...
Brain Health Supplements Market Size, Share & Trends Analysis Report By Product (Natural Molecules, Herbal Extract), By Application, By Region, And Segment Forecasts, 2022 - 2030 Brain Health Supplements Market Growth & Trends The global brain health supplements market size is expected to...
332 pages •
By Future Market Insight Global & Consulting Pvt Ltd
• Mar 2022
A recent market study published on the market offers global industry analysis for 2014-2021 & opportunity assessment for 2022–2032. The study offers a comprehensive assessment of the more important market dynamics. After conducting thorough research on the historical and current growth parameters of the CNS Treatment and Therapy Market,...
The North America Femtech Market would witness market growth of 9.9% CAGR during the forecast period (2022-2028). Infectious diseases are becoming more common among women in various areas, prompting an increase in financing. These kind of financial donations and grants help to digitalize women’s health. Femtech allows women all around...
350 pages •
By The Business Research Company
• Feb 2022
Major companies in the residential substance abuse and mental health facilities market include Kaiser Permanente, universal health services, Ohio Department of Mental Health and Addiction Services, NHS England, Acadia Healthcare Company, CareTech Holdings PLC and Pyramid Healthcare. The global residential substance abuse and mental...
The behavioral rehabilitation market is projected to reach US$ 540.84 million by 2028 from US$ 350.63 million in 2021; it is estimated to grow at a CAGR of 6.4% from 2021 to 2028. Drug manufacturers play a critical role in introducing new products to cope with the global market’s demands. For instance, in May 2021, Lybalvi (olanzapine...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.